News & Updates
Filter by Specialty:
Bloodstream infection tied to ICU admission, death in children hospitalized for flu
Bloodstream infections rarely occur in children hospitalized for influenza but are associated with intensive care unit (ICU) admission, mechanical ventilation, longer hospital stay, and higher in-hospital mortality, according to a study.
Bloodstream infection tied to ICU admission, death in children hospitalized for flu
18 Mar 2024Broaden screening in patients with TB or HBV, says study
Patients with hepatitis B virus (HBV) infection are at heightened risk of latent tuberculosis (TB), while those with latent TB are also at increased risk of HBV infection, reveals a study. Notably, the risk of co-infection is highest among Asians and those born in high-incidence countries.
Broaden screening in patients with TB or HBV, says study
17 Mar 2024When is the best time for kids to get flu vaccine?
Birth month is predictive of influenza vaccination timing in young children, owing to its impact on the scheduling of preventive care visits, reports a US study. Specifically, children born in October are more likely to be vaccinated in the same month and less likely to be diagnosed with influenza, supporting recommendations that promote October vaccination.
When is the best time for kids to get flu vaccine?
16 Mar 2024Lockdown-induced inactivity may impair teens’ metabolic profile
Forced sedentary behaviour, brought about by the COVID-19 lockdown, has negative effects on the metabolic and inflammatory profile of many teenagers, which can potentially lead to long-term poor health outcomes, suggests a study.
Lockdown-induced inactivity may impair teens’ metabolic profile
15 Mar 2024Is ART-free remission feasible in children born with HIV who received ART very early in life?
In the IMPAACT* P1115 study presented at CROI 2024, four children who received antiretroviral therapy (ART) for HIV very early in life remained free of detectable HIV for over a year after a break in their ART regimen.
Is ART-free remission feasible in children born with HIV who received ART very early in life?
13 Mar 2024Novel investigational combo a breakthrough in HIV treatment?
Phase II data presented at CROI 2024 demonstrated the ability of an investigational, long-acting, oral once-weekly regimen comprising islatravir, a nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a first-in-class capsid inhibitor, to maintain viral suppression at week 24 in virologically suppressed people living with HIV (PWH).